Long-term responders to enzalutamide (ENZA) during the phase III AFFIRM trial: Baseline characteristics and efficacy outcomes Meeting Abstract
| Authors: | Fleming, M. T.; Scher, H. I.; Fizazi, K.; Taplin, M. E.; Forer, D.; Hirmand, M.; De Bono, J. S. |
| Abstract Title: | Long-term responders to enzalutamide (ENZA) during the phase III AFFIRM trial: Baseline characteristics and efficacy outcomes |
| Meeting Title: | 2013 Genitourinary Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 31 |
| Issue: | 6 Suppl. |
| Meeting Dates: | 2013 Feb 14-16 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2013-02-20 |
| Language: | English |
| ACCESSION: | WOS:000333679600023 |
| DOI: | 10.1200/jco.2013.31.6_suppl.20 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 20 -- Source: Wos |
